CVE-2025-52653
MEDIUMCVSS 5.4/10EPSS 0.24%
Last modified
CVE-2025-52653 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.. EPSS estimates a 0.24% chance of exploitation in the next 30 days.
Description
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Hcltech | Dryice Myxalytics | 6.6 |
References
Timeline
- Published
- Last Modified
- Status
- Analyzed
Frequently Asked Questions
What is CVE-2025-52653?
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
How severe is CVE-2025-52653?
CVE-2025-52653 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 0.24% probability of exploitation in the next 30 days.
How do I fix CVE-2025-52653?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2025-52653?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST